Page last updated: 2024-09-03

3-mercapto-3,3-cyclopentamethylenepropionic acid and zm 241385

3-mercapto-3,3-cyclopentamethylenepropionic acid has been researched along with zm 241385 in 1 studies

Compound Research Comparison

Studies
(3-mercapto-3,3-cyclopentamethylenepropionic acid)
Trials
(3-mercapto-3,3-cyclopentamethylenepropionic acid)
Recent Studies (post-2010)
(3-mercapto-3,3-cyclopentamethylenepropionic acid)
Studies
(zm 241385)
Trials
(zm 241385)
Recent Studies (post-2010) (zm 241385)
5024013124

Protein Interaction Comparison

ProteinTaxonomy3-mercapto-3,3-cyclopentamethylenepropionic acid (IC50)zm 241385 (IC50)
Adenosine receptor A3Rattus norvegicus (Norway rat)0.0949
Adenosine receptor A2aHomo sapiens (human)0.0216
Adenosine receptor A2bHomo sapiens (human)0.0646

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaimovitz, C; Douvdevani, A; Eini, H; Frishman, V; Kachko, L; Lewis, EC; Yulzari, R1

Other Studies

1 other study(ies) available for 3-mercapto-3,3-cyclopentamethylenepropionic acid and zm 241385

ArticleYear
Caffeine promotes anti-tumor immune response during tumor initiation: Involvement of the adenosine A2A receptor.
    Biochemical pharmacology, 2015, Nov-01, Volume: 98, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Animals; Caffeine; Cell Line, Tumor; Cyclopentanes; Fibrosarcoma; Mice; Mice, Knockout; Neoplasms, Experimental; Receptor, Adenosine A2A; Triazines; Triazoles

2015